Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

415 Capital

WebsiteLinkedIncbCrunchbase
Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • USA
  • Switzerland
  • France
Investment stages
  • Seed
Industries
  • Fintech
  • AI
  • Data science
  • Health tech
About
415 Capital: Specializing in MedTech venture capital, we partner with entrepreneurs to bring life-saving medical innovations to market, leveraging expertise and successful portfolio exits with industry giants like Philips and Boston Scientific.
Min check size
$1M
Max check size
$30M
Fund size
NPS

Investment Thesis

415 Capital invests in innovative medical technologies that address significant unmet needs in chronic diseases, particularly in cardiovascular and neurovascular areas, which are leading causes of death and major cost drivers in global healthcare systems. The firms approach involves identifying and nurturing technologies that have the potential to revolutionize treatment and improve patient outcomes.
Lead investor
Co Invest
Number of exits
Preferred contact method

415 Capital Contacts Information

Primary contact

Secondary contact

Portfolio

Endovascular Engineering

Laza Medical

Supira Medical

R3 Vascular

CorFlow Therapeutics

Cardiac Success

Hilo

Distalmotion

TRiCares

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp